AUKI Pharma ApS: Financial statements 2022
CVR: 43030493
Source: annual report 2022, Danish Business Authority
01/02/2022 – 31/12/2022
AUKI Pharma ApS (CVR 43030493) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 57,015 and a net result of DKK -36,750. Equity in the 2022 report amounted to DKK 3,250. The solvency ratio was 0.2%.
- Gross Profit
- DKK 57,015
- Profit/Loss
- DKK -36,750
- Equity
- DKK 3,250
- Total Assets
- DKK 1,702,797
- Employees
- 0
Official annual report
Keep an eye on AUKI Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of February 1, 2022, Eystein Eyðunsson Elttør is registered as director of AUKI Pharma ApS.
AUKI Pharma ApS was founded on February 1, 2022.
About AUKI Pharma ApS
AUKI Pharma ApS was a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2022. The company has been dissolved on 15 September 2025. The company was registered under the industry Fremstilling af andre fødevarer i.a.n.. The company has 1 employee (2022). In 2023, the company reported revenue of DKK 5,390 and a net result of DKK -19,190 compared with DKK -36,750 the year before. Equity in the 2023 report amounted to DKK -15,931.